$36.03
-2.28-5.95%
最終更新: Oct 22, 4:33 PM
$35.94
-2.37-6.19%
Benzinga
Benzinga
Benzinga
金曜日, 10 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Harmony Biosciences Hldgs (HRMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Harmony Biosciences Hldgs (HRMY) は、8 4, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$1B - $1.04Bの範囲と予想しています。
以前のガイダンスと比較して、Harmony Biosciences Hldgsは売上高予測を以前の範囲である維持から$1B - $1.04Bに引き上げました。
Harmony Biosciences Hldgsは、23から1 8, 2024の間に8 4, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 4 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.05 | $0.90 | $0.98 | $0.88 |
| Actual | $1.28 | $0.55 | $0.57 | $1.08 |
| Surprise | +21.9% | -38.9% | -41.8% | +22.7% |
| Revenue | ||||
| Estimate | $242.1M | $221.2M | $241.5M | $225.2M |
| Actual | $261.3M | $215.4M | $243.8M | $239.5M |
| Surprise | +7.91% | -2.61% | +0.95% | +6.33% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.38 | $1.42 | $0.83 | $0.98 |
| Revenue | ||||
| Consensus | $274.0M | $282.1M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.28 | $1.05 | 21.9 % |
| Q1 | May 7, 2026 | $0.55 | $0.90 | -38.9 % |
| Q4 | Feb 24, 2026 | $0.57 | $0.98 | -41.8 % |
| Q3 | Nov 4, 2025 | $1.08 | $0.88 | 22.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $261.30M | $242.15M | 7.91 % |
| Q1 | May 7, 2026 | $215.40M | $221.17M | -2.61 % |
| Q4 | Feb 24, 2026 | $243.78M | $241.47M | 0.95 % |
| Q3 | Nov 4, 2025 | $239.46M | $225.19M | 6.33 % |